Mama-Match
NextMeds review
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter.
- HSA / FSA eligible
- Independently scored
- No insurance needed
Every medical claim is cited to its primary source — the clinical trial or the FDA label — so you can open it and check it yourself. No one on this team is your healthcare professional. What follows is friendly information, never medical advice.
Gentler first steps than NextMeds
Providers to compare, with referral partners listed first. Placement and score are separate; some links earn MamaGLP a commission.
- Meet CoreAge Rx
Compounded semaglutide and tirzepatide with advertised flat prices; clarify the offer and renewal rules before paying.
- Meet Gala Health
$179/mo for either medication, flat across doses, with a genuinely gentle microdose tier — if you can live with an annual plan and a pharmacy it will not name.
- Meet Oak
From $119/mo semaglutide, $185/mo tirzepatide, fully asynchronous with free delivery — the real monthly price and the cancellation terms only appear after you sign up.
NextMeds at a glance
- Semaglutide
- $79/mo, same price at every dose
- Tirzepatide
- $119/mo, same price at every dose
- Coverage
- All 50 states
- Brand-name
- Compounded only
How we scored NextMeds
Each factor is judged from NextMeds's actual pricing, disclosures and support, then combined into the Mama-Match Score of 60/100 using the same weighted six-factor framework we apply to every provider — never influenced by whether a provider pays us.
The start feels transactional — more cash register than welcome.
The cost is unpredictable, hidden behind a quiz, or in the premium range.
Little public detail about who oversees your care, and how.
Available in all 50 states, so where you live is not a barrier.
Support is thin once the prescription ships.
Canceling carries real friction — commitments, notice windows or non-refundable charges.
How we verified this review
- Last reviewed
- August 2026
- Confidence
- High
$79 and $119, flat at every dose, and every monthly figure reconciles exactly against its period total — something many here fail to manage. The 'Was $199' anchor beside them is the renewal price of a retired offer, a rate this offer has never charged.
What to expect when you sign up
We walked NextMeds's public signup (August 2026) — a first-hand look at the process. We did not create accounts, enter medical information, or complete checkout, so this is what any visitor sees, not a patient's outcome.
- 1The signup call to action stays on nextmeds.com (https://www.nextmeds.com/consultation?offer=offer_v9_tm)
What we noticed
- A monthly price is visible on the public homepage before any intake — you do not have to hand over information to see a number
Pricing
Prices re-verified
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injection, month to monthThe standing rate, and the renewal rate — declared as the same object as the joining price in the live offer's own checkout data. |
| Compounded semaglutide | $76 | Injection, 3-month plan$228 for the period. |
| Compounded semaglutide | $73 | Injection, 6-month plan$438 for the period. |
| Compounded semaglutide | $49 | Injection, 12-month plan$588 for the period. This is the figure the homepage advertises as its starting price. |
| Compounded tirzepatide | $119 | Injection, month to monthThe standing rate, and the renewal rate. |
| Compounded tirzepatide | $115 | Injection, 3-month plan$345 for the period. |
| Compounded tirzepatide | $110 | Injection, 6-month plan$660 for the period. |
| Compounded tirzepatide | $99 | Injection, 12-month plan$1,188 for the period. This is the second figure the homepage advertises. |
Swipe the table to see plan details →
HSA/FSA is usually accepted for GLP-1 telehealth — check your plan. Prices reflect what NextMeds disclosed publicly at our last review and change often; confirm the current number on NextMeds's site.
What we like
- The renewal price is the same as the joining price on the live offer, confirmed in its own checkout data rather than from marketing copy
- Genuinely flat: the same rate at every dose on both molecules
- $79 month-to-month for semaglutide is among the lowest standing rates on this roster
- Every advertised per-month figure reconciles exactly against its period total ($228 over three months is $76, $588 over twelve is $49)
- Names two compounding pharmacies outright, with phone numbers — The Pharmacy Hub and Foothills Pharmacy
- Names its clinical group, OpenLoop Healthcare Partners, PC
- A full refund is available if a provider finds you medically ineligible
- Ships to all 50 states by its own FAQ
The caveats
- ⚠ Operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds — four consumer brands from one company rather than four independent options
- ⚠ That operator carries an FDA warning letter: issued 8 June 2026 to Trinity HealthCare Supply, LLC dba altRx, MARCS-CMS 728236, for false and misleading claims and misbranding in telehealth, with no close-out recorded
- The advertised $49 and $99 are the twelve-month totals divided by twelve, printed under the words 'SAME PRICE EVERY MONTH'; the month-to-month rates are $79 and $119
- The 'Was $199' anchor beside them is the retired offer's renewal price, a rate this offer has never charged
- The countdown is not a deadline — it read 'ENDS AUGUST 15TH' and then 'AUGUST 20TH' within the same hour, and the offer's own stored end date is June 30th
- The 'Save $110' and 'Save $150' figures imply reference prices of $189 and $269, which do not match the $199 shown in the hero
- Your order becomes non-refundable as soon as you submit the intake, before a clinician has reviewed it
- Refund requests must be made in writing within 28 days of payment
- How many weeks of medication a charge buys is never stated — and its sibling brand Trinity Meds, on the same platform, defines its month as four weeks
- Nothing on the public site addresses pregnancy, breastfeeding, PCOS or menopause
- Compounded only, with no brand-name lane and no oral form
NextMeds for moms: our verdict
Compounded semaglutide at $79 a month and tirzepatide at $119, month to month, with no dose-based increase and — checked in its own checkout data rather than taken on trust — a renewal price identical to the joining price. That last part is rarer than it should be. Two things the homepage will not tell you. The $49 and $99 it advertises are the twelve-month totals divided by twelve, not a monthly rate you can start on, and the countdown beside them is not a real deadline: it read August 15th and then August 20th within the same hour. The larger caveat is corporate. NextMeds is operated by Trinity HealthCare Supply, LLC, which also runs Lean Meds, altRx and Trinity Meds, and that operator holds an open FDA warning letter. It runs about $79/mo, flat across every dose — toward the affordable end of what we track.
We looked at NextMeds the way moms actually have to: not just the monthly cost, but the right timing around pregnancy and nursing and honest, clear pricing from the start — the parts a generic weight-loss review skips.
What NextMeds actually costs
- Compounded semaglutide — Injection, month to month: $79/mo
- Compounded semaglutide — Injection, 3-month plan: $76/mo
- Compounded semaglutide — Injection, 6-month plan: $73/mo
- Compounded semaglutide — Injection, 12-month plan: $49/mo
- Compounded tirzepatide — Injection, month to month: $119/mo
- Compounded tirzepatide — Injection, 3-month plan: $115/mo
That lands below the median ongoing price of about $177 across the providers we track for moms — a real cost advantage.
NextMeds prices flat across doses, so it doesn't climb as your dose does — which matters, because most women spend months titrating up.
That price covers the consult and the medication.
The medications NextMeds prescribes
NextMeds lists semaglutide and tirzepatide. Offering both gives a prescribing clinician options, but PCOS or a history of gestational diabetes alone does not establish which medication is right for you. Compounded GLP-1s are not FDA-approved finished products. Confirm the exact formulation and dispensing pharmacy; an approved brand’s trial results do not establish the quality or equivalence of a compounded product.
Where it operates. NextMeds lists its coverage as: All 50 states.
Where NextMeds fits — and where it doesn't — for moms
A good fit if…
- you want a real clinician who reads your history with the right timing around pregnancy and nursing in mind, not a questionnaire that approves you automatically.
- the monthly cost is a real barrier and you want a low, predictable number.
- you want to discuss both semaglutide and tirzepatide with your prescribing clinician.
- uninterrupted nationwide access matters to you — a move for the family shouldn't interrupt your care.
Look elsewhere if…
- you specifically want an FDA-approved brand-name pen with its own pregnancy and breastfeeding label.
- a clean regulatory record is non-negotiable for you — look at the FDA warning letter flagged in the cons above.
Trust, safety and oversight
Our confidence in NextMeds's public data is high — the pricing, the pharmacies and the clinical network were all verifiable at our last review. It has an FDA warning letter, flagged in the cons — read it before you start. As with any compounded GLP-1, the most useful thing moms can do is confirm which licensed pharmacy fills the prescription and what's in the formula — we explain how we score oversight in our scoring methodology.
Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
The bottom line
NextMeds is a genuine bargain for the price — weigh it on the right timing around pregnancy and nursing and honest, clear pricing from the start against the alternatives below. For moms comparing another compounded offer, CoreAge Rx describes prices and terms to confirm for the selected dose and plan.
The bottom line
Best for: Someone who wants a genuinely flat month-to-month rate and will ignore both the countdown and the twelve-month headline — and who knows they are not choosing independently of Lean Meds or Trinity Meds.
Keep comparing NextMeds
Head-to-heads and alternatives
Ranked boards
- Best GLP-1 for moms — a gentle first step
- Best GLP-1 for women — PCOS, cycles, perimenopause
- Best GLP-1 for first-timers (easiest to start)
- Most affordable GLP-1 with honest, clear pricing
- Best semaglutide for mothers — price and practicality
- Best semaglutide for women — compounded vs brand
- Best semaglutide for young moms — postpartum and budget
- Best tirzepatide for mothers — is it worth the extra
- Best tirzepatide for women — PCOS and insulin resistance
- Best GLP-1 with bilingual / Spanish-language support
NextMeds, answered
- How much does NextMeds cost?
- As of our last review, NextMeds's published pricing starts around $79/mo ($79/mo, same price at every dose semaglutide, $119/mo, same price at every dose tirzepatide). Confirm the current all-in price on NextMeds's site before you commit.
- Is NextMeds safe to use while breastfeeding?
- Pregnancy and breastfeeding need separate discussions with your clinician. GLP-1 weight-loss treatment is not recommended during pregnancy. During breastfeeding, the exact drug and formulation matter: Wegovy tablets are not recommended because of the SNAC absorption ingredient. Injectable semaglutide and tirzepatide labels call for weighing benefits, risks and the limits of infant-safety data; they do not establish that treatment is safe for every nursing parent. Compounded products do not inherit FDA approval from the branded drug. Discuss your own medication and timing before starting or changing treatment.
- Does NextMeds offer both semaglutide and tirzepatide?
- Yes — NextMeds offers both. The choice depends on the exact product, your medical history and your clinician’s assessment; PCOS or a history of gestational diabetes alone does not make one medication the preferred treatment.
- Where does NextMeds land in your ranking?
- NextMeds scores 60/100 on our Mama-Match Score (rank #117), which weights six things that matter to a first-timer. Compare the scorecards and our published methodology before choosing a program.
Prices, states and verification reflect what NextMeds disclosed publicly at our last review; the Mama-Match Score is our editorial judgment under the published methodology. This is background information, not medical advice. Pregnancy and breastfeeding guidance depends on the drug and formulation. Read the current Wegovy label and Zepbound label. See our medical disclaimer and how we're funded.